ARS Pharmaceuticals (SPRY) Cash & Current Investments (2020 - 2026)
ARS Pharmaceuticals (SPRY) posted Cash & Current Investments of $143.8 million for Q2 2026, down 40.1% from $240.1 million a year earlier and down 28.5% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals' Cash & Current Investments came in at $245 million, down 22.0% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- In prior years, ARS Pharmaceuticals' Cash & Current Investments was $314 million in FY2024 (+37.5%), $228.4 million in FY2023 (-12.9%), $262.3 million in FY2022 (+336.7%) and $60.06 million in FY2021 (-84.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q4 2021.
- On a year-over-year basis, Cash & Current Investments has declined in each of the last three quarters, with growth averaging 0.9% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2022, with growth of 336.7%; the weakest was Q4 2021, with a decline of 84.5%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $201 million (Q1 2026), $245 million (Q4 2025) and $288.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | ARS Pharmaceuticals | 404.71 Mn | 260.91 Mn | 20.81 Mn | 143.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.80 Mn |
| Mar 31, 2026 | 201.00 Mn |
| Dec 31, 2025 | 245.00 Mn |
| Sep 30, 2025 | 288.20 Mn |
| Jun 30, 2025 | 240.10 Mn |
| Mar 31, 2025 | 275.70 Mn |
| Dec 31, 2024 | 314.00 Mn |
| Sep 30, 2024 | 204.60 Mn |
| Jun 30, 2024 | 218.70 Mn |
| Mar 31, 2024 | 223.60 Mn |
| Dec 31, 2023 | 228.40 Mn |
| Sep 30, 2023 | 241.90 Mn |
| Jun 30, 2023 | 252.20 Mn |
| Mar 31, 2023 | 264.50 Mn |
| Dec 31, 2022 | 262.30 Mn |
| Sep 30, 2022 | 266.62 Mn |
| Jun 30, 2022 | 257.98 Mn |
| Mar 31, 2022 | 253.85 Mn |
| Dec 31, 2021 | 60.06 Mn |
| Sep 30, 2021 | 300.66 Mn |
API Access
ARS Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();